Prognosis of adult-onset clinically amyopathic dermatomyositis treated with only topical therapy

J Dermatol. 2017 Jul;44(7):e178-e179. doi: 10.1111/1346-8138.13822. Epub 2017 Mar 7.

Authors

Yoshimi Matsuo¹, Shoji Mihara¹, Akio Tanaka¹, Mikio Kawai¹, Michihiro Hide¹

Affiliation

¹ Department of Dermatology, Integrated Health Sciences, Institute of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.

PMID: 28266052
DOI: 10.1111/1346-8138.13822

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Administration, Topical
Adrenal Cortex Hormones / administration & dosage*
Adult
Aged
Aged, 80 and over
Dermatomyositis / drug therapy*
Female
Humans
Immunosuppressive Agents / administration & dosage*
Male
Middle Aged
Prognosis
Retrospective Studies
Tacrolimus / administration & dosage*
Treatment Outcome

Substances

Adrenal Cortex Hormones
Immunosuppressive Agents
Tacrolimus

Supplementary concepts

Amyopathic dermatomyositis